Company: SVREW
Filing Date: 2025-03-21
Form Type: 20-F
Source: 0001013762-25-001028
Chunk: 162

Company: SaverOne 2014 Ltd.
Filing Date: 2025-03-21
Form: 20-F
Item: Item 19
Chunk 162
---

Israeli Shekels in thousands, except per share and share data)

Note
2 - Material accounting policies (Cont.)

  A                                                                                             

Lack
of exchangeability - Amendments to IAS 21

In
August 2023, the IASB issued amendments to IAS 21 The Effects of Changes in Foreign Exchange Rates to specify how an entity should assess
whether a currency is exchangeable and how it should determine a spot exchange rate when exchangeability is lacking. The amendments also
require disclosure of information that enables users of its financial statements to understand how the currency not being exchangeable
into the other currency affects, or is expected to affect, the entity’s financial performance, financial position and cash flows.
The amendments will be effective for annual reporting periods beginning on or after 1 January 2025. Early adoption is permitted, but
will need to be disclosed. When applying the amendments, an entity cannot restate comparative information.

The
amendments are not expected to have a material impact on the Company’s financial statements.

Note
3 - Significant accounting estimates and considerations

The
accounting estimates and assumptions that were used in the preparation of the financial statements are tested on a regular basis and
are based on past experience and other factors, including future events, the occurrence of which is reasonably expected to occur in view
of existing circumstances. The Company makes estimates and assumptions regarding future events or conditions. By their very nature, it
is rare that such accounting estimates will be identical to actual results. The estimates and assumptions that reflect the highest exposure
to material changes in the amount of assets and liabilities in the following year are set out below:

  Impairment    

Inventory
impairment exists when the cost exceeds the net realizable value. Net realizable value is the estimated selling price in the ordinary
course of business, less estimated costs of completion and the estimated costs necessary to make the sale.

Management
estimates the net realizable values of inventories, taking into account the most reliable evidence available at each reporting date.
The future realization of these inventories may be affected by future technology, competition, demands or other market-driven changes
that may reduce future selling prices or affect customer demand for the company products.

  Research                  

Development
expenses are capitalized and recorded as an asset, commencing with the phase during which technological feasibility is achieved, when
the company has intentions and the ability to complete and use (or sell) the asset, when it is expected that the developed asset will